Headline: CPT code 68525: Lacrimal Sac Biopsy Gains Clinical Attention

CPT code 68525 denotes a surgical biopsy of the lacrimal sac (the upper dilated end of the nasolacrimal duct) to obtain tissue for diagnostic pathology. The code captures a focused ocular diagnostic procedure performed by ophthalmologists or oculoplastic surgeons when clinical concern exists for infection, chronic inflammation, or malignancy of the tear drainage apparatus. Nationally, precise coding for this procedure supports clinical decision-making, appropriate site-of-service classification, and accurate claims processing for relatively infrequent but clinically significant interventions.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical context and typical sites of service, billing and coding considerations relevant to payers listed above, and benchmarking themes where available. The publication outlines where this code fits within procedural portfolios for ophthalmology and oculoplastic surgery and summarizes common documentation elements needed to justify medical necessity.

This piece is intended for billing managers, practice administrators, and clinicians seeking a concise national briefing on CPT code 68525, including clinical purpose, coverage landscape, and areas to review in payer contracts and internal billing workflows.